Plain-English translation of NCT03712774 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows patients with esophageal cancer as they undergo chemotherapy combined with radiation therapy. Researchers want to understand how this treatment affects your quality of life, side effects, and overall health outcomes. You won't be randomly assigned to a new treatment — instead, doctors will follow your health journey and ask you regular questions about how you're feeling and functioning.
While chemotherapy and radiation can help treat esophageal cancer, doctors need better information about how these treatments impact patients' day-to-day lives, physical function, and long-term well-being. This study will help future patients by measuring real experiences and identifying ways to improve care.
You likely qualify if…
You likely don't qualify if…
You will continue with your planned cancer treatment (chemotherapy and radiation, with or without surgery) as recommended by your doctor. Throughout and after your treatment, you'll be asked to complete questionnaires at regular intervals that ask about your quality of life, physical function, side effects, and overall well-being. The study will track you over time to see how you're doing and compare what you report about your experience with what your doctors observe.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Germany
Sponsor
Ludwig-Maximilians - University of Munich
Enrollment target
~60 participants
Started
October 2018
Primary completion
December 2021
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2018.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Falk Roeder, MD
Ludwig-Maximilians Universität München
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.